Favorable prognosis in patients with high-grade glioma with radiation necrosis: The University of Colorado reoperation series

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 1, 2011, Pages 211-217

  Rusthoven, Kyle E ^a   Olsen, Christine ^a   Franklin, Wilbur ^a   Kleinschmidt Demasters, B K ^a   Kavanagh, Brian D ^a   Gaspar, Laurie E ^a   Lillehei, Kevin ^a   Waziri, Allen ^a   Damek, Denise M ^a   Chen, Changhu ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoradiation therapy; Glioblastoma; High grade glioma; Radiation necrosis; Radiotherapy

Indexed keywords

CHEMORADIOTHERAPY; CHEMOTHERAPY; PATHOLOGY; RADIOTHERAPY; TUMORS;

CHEMORADIATION THERAPIES; GLIOBLASTOMAS; HIGH-GRADE GLIOMAS; METHODS AND MATERIALS; PROPORTIONAL HAZARDS; RADIATION NECROSIS; UNIVERSITY OF COLORADO; WORLD HEALTH ORGANIZATION;

DIAGNOSIS;

TEMOZOLOMIDE;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION NECROSIS; RECURRENT CANCER; REOPERATION; RETROSPECTIVE STUDY; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 79961126564     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.04.069     Document Type: Article

References (28)

1. M.D. Walker, E. Alexander Jr., and W.E. Hunt Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial J Neurosurg 49 1978 333 343 (Pubitemid 9013313)
2. M.D. Walker, S.B. Green, and D.P. Byar Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery N Engl J Med 303 1980 1323 1329 (Pubitemid 11194457)
3. M.D. Walker, T.A. Strike, and G.E. Sheline An analysis of dose-effect relationship in the radiotherapy of malignant gliomas Int J Radiat Oncol Biol Phys 5 1979 1725 1731 (Pubitemid 10187518)
4. N.M. Bleehen, and S.P. Stenning A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party Br J Cancer 64 1991 769 774
5. J.D. Ruben, M. Dally, and M. Bailey Cerebral radiation necrosis: Incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy Int J Radiat Oncol Biol Phys 65 2006 499 508
6. E. Shaw, R. Arusell, and B. Scheithauer Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: Initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study J Clin Oncol 20 2002 2267 2276 (Pubitemid 34441653)
7. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996 (Pubitemid 40349501)
8. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
9. M.C. Chamberlain, M.J. Glantz, and L. Chalmers Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma J Neurooncol 82 2007 81 83
10. C. Peca, R. Pacelli, and A. Elefante Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: Tumour progression or radionecrosis? Clin Neurol Neurosurg 111 2009 331 334
11. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
12. D.R. Cox Regression models and life-tables J R Stat Soc 34 1972 187 202
13. W. Taal, D. Brandsma, and H.G. de Bruin Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide Cancer 113 2008 405 410
14. D. Brandsma, L. Stalpers, and W. Taal Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas Lancet Oncol 9 2008 453 461 (Pubitemid 351597795)
15. A.A. Brandes, E. Franceschi, and A. Tosoni MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients J Clin Oncol 26 2008 2192 2197
16. G.B. Roldán, J.N. Scott, and J.B. McIntyre Population-based study of pseudoprogression after chemoradiotherapy in GBM Can J Neurol Sci 36 2009 617 622
17. M.M. Fitzek, A.F. Thornton, and J.D. Rabinov Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: Results of a phase II prospective trial J Neurosurg 91 1999 251 260
18. N.S. Floyd, S.Y. Woo, and B.S. Teh Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme Int J Radiat Oncol Biol Phys 58 2004 721 726 (Pubitemid 38221127)
19. M. Mizumoto, K. Tsuboi, and H. Igaki Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme Int J Radiat Oncol Biol Phys 77 2010 98 105
20. Radiation Therapy Oncology Group. Radiation Therapy Oncology Group toxicity criteria. Available at: http://www.rtog.org. Accessed December 12, 2009.
21. Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health. Common terminology criteria for adverse events v3.0 (CTCAE). Available at: http://ctep.cancer.gov/protocolDevelopment/electronic- applications/docs/ctcaev3.pdf. Accessed March 18, 2010.
22. W. Hollingworth, L.S. Medina, and R.E. Lenkinski A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors AJNR Am J Neuroradiol 27 2006 1404 1411 (Pubitemid 44260118)
23. M. Law, S. Yang, and H. Wang Glioma grading: Sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging AJNR Am J Neuroradiol 24 2003 1989 1998 (Pubitemid 37444849)
24. P.A. Hein, C.J. Eskey, and J.F. Dunn Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: Tumor recurrence versus radiation injury AJNR Am J Neuroradiol 25 2004 201 209 (Pubitemid 38235296)
25. M. Plotkin, J. Eisenacher, and H. Bruhn 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: A comparative study J Neurooncol 70 2004 49 58 (Pubitemid 39193997)
26. W. Chen Clinical applications of PET in brain tumors J Nucl Med 48 2007 1468 1481 (Pubitemid 47397397)
27. A.H. Aiken, S.M. Chang, and D. Larson Longitudinal magnetic resonance imaging features of glioblastoma multiforme treated with radiotherapy with or without brachytherapy Int J Radiat Oncol Biol Phys 72 2008 1340 1346
28. M.E. Hegi, A.C. Diserens, and T. Gorlia MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 997 1003 (Pubitemid 40349502)